TickerTalks
Browse all tickers →
TickerTalks›$CNC
CNCNC

Centene Corp.

$CNC·$31B·Medical - Healthcare Plans·Healthcare
$62.99+3.3%YTD+53.0%1Y+71.1%
Price updated 3h ago·X counts updated 5d ago
CNCNC
$CNCCentene Corp.
$62.99+3.28%103 posts0.9×
AI analysisFundamentalsVoices on X
Loading…

On X

The complete picture of $CNC on X — how loud the conversation is right now, how it has trended over the last two weeks, and which way the crowd is leaning.

103X posts · last 7 days
Sep 20Sep 27
Chatter Meter
0.9×
QuietNormal · 1×Loud

How loud $CNC's conversation on X is versus its own normal — 1× is typical, higher means busier. Right now it's about its usual level.

Bullish sentimentAI analysisGenerated by AI from underlying data5 posts analyzed · as of 2026-09-10

Centene is being flagged as a technical setup — a 3-month H&S continuation forming with a Minervini-style leader coming out of ADX compression, inverse H&S alignment above the 75MA. A separate Canada Nickel Corp thread files new NI 43-101 technical reports. Both threads constructive; no bear voice.

Read what X is saying about $CNC

  • Bullish vs bearish call — with the AI summary of the day's posts
  • Divergence flag when the top-engagement posts argue the other side
  • How loud the conversation is versus this ticker's own normal
Free, forever. No credit card.

AI verdictAI analysisGenerated by AI from underlying data

TickerTalks' own read on what's driving $CNC — fundamentals, momentum, or an event — and whether it agrees with the X crowd.

Proven numbersAcceleratingAI verdict · as of 2026-10-02

The move is getting stronger, with heavier trading behind it.

Centene at 77% of 52-week range — up 48% YTD, Minervini-style leader setup after H&S continuation.

Centene Corporation is a managed-care provider — Medicaid, Medicare Advantage, Marketplace plans serving under-insured populations. The stock is up 48% YTD and 77% of its 52-week range on specific technical and operational momentum.

  • The P&L is working again: revenue grew 7.1% YoY to $49.94B last quarter at a 3.7% operating margin and EPS $3.13 — the operating margin recovery and medical-loss-ratio stabilization is the specific inflection bulls lean on.
  • The technical setup is specific: 3-month H&S continuation forming with a Minervini-style leader coming out of ADX compression, inverse H&S alignment above the 75MA — chart-driven buying from a specific setup framework.
  • No insider selling in the window; director A-Awards (Tyler, Coughlin, Eppinger) are routine; the volume at 1.18x normal is supportive-accumulation.

Accelerating holds while Medicaid/Marketplace enrollment extends and medical-loss-ratio stays controlled. A soft Oct 27 earnings print on MLR, or any specific commentary on Marketplace-related regulatory risks, is what cools the move; a FY27 EPS guide above $8 plus specific Medicare Advantage star-rating improvements is what extends the breakout toward prior cycle highs.

Agrees with X sentimentX bulls on the Minervini-style leader framework, 3-month H&S continuation with ADX compression, and the inverse-H&S alignment above the 75MA are reading the technical setup correctly — this is a specific chart-plus-fundamentals breakout.

What to watch: Oct 27 earnings — Medicaid/Marketplace enrollment growth, medical-loss-ratio stability, Medicare Advantage star-ratings, FY27 EPS guide. A soft MLR print or Marketplace regulatory concern is what cools the breakout.

On the calendar: 2026-10-27 — Q3 FY26 earnings

Read the AI verdict on $CNC

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • Whether TickerTalks' read agrees with or diverges from the X crowd
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Managed care organization operating Medicaid, Medicare, and ACA marketplace health plans for under-insured populations across 30+ U.S. states.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Healthcare Plans sits in its cycle right now — and what that implies for $CNC.

Medical - Healthcare Plans · Healthcare

Medicaid redeterminations (post-COVID eligibility reviews) have reduced Medicaid enrollment ~15M from peak, improving commercial insurance mix at managed care organizations; Medicare Advantage star ratings and benchmark rate adjustments are the primary 2026 earnings variable. MLR creep from utilization recovery and GLP-1 pharmacy costs are the key margin headwinds.

What this means for $CNC

Partial — Managed care organization operating Medicaid, Medicare, and ACA marketplace health plans for under-insured populations across 30+ U.S. states.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+14.7%YTD
+10.4%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
-5.2How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
-17.7%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
-3.7%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
18.9%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.2Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
-28.7%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
14.9%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.8Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 28, 2026$2.51$1.09+130.3%
Q1 2026Apr 28, 2026$3.37$2.23+51.1%
Q4 2025Feb 6, 2026$-1.19$-1.22+2.5%
Q3 2025Oct 29, 2025$0.50$-0.14+445.4%
Next earningsTue, Oct 27·consensus EPS $0.10

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$49.9B+7.1%21.9%3.7%$3.13$3.4B
Q4 FY25$49.7B+21.9%15.2%-3.5%$-2.24$224.0M
Q3 FY25$49.7B+18.2%16.4%-14.0%$-13.50$1.1B
Q2 FY25$48.7B+22.4%6.0%-0.9%$-0.51$1.6B

Forward consensus

5-year forecast · up to 14 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$196.2B$194.3B – $199.7B$4.87$4.78 – $5.0712
FY27$193.0B$189.8B – $196.0B$5.30$4.95 – $6.2012
FY28$199.4B$187.1B – $208.7B$6.54$6.08 – $7.2114
FY29$202.6B$196.1B – $207.8B$8.71$8.34 – $9.008
FY30$209.4B$202.6B – $214.8B$9.84$9.43 – $10.1712

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1.2×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.77%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-5.8%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+15.8%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatHigh float · 483.3M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.1% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β1.115-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellAug 26Christopher KosterSecretary & General Counsel56.5K sh$3.8MSellAug 18Christopher KosterSecretary & General Counsel47.6K sh$3.1MSellJun 10Kenneth A BurdickDirector80.0K sh$5.2M
+ 25 other (21 awards · 3 inkinds · 1 discretionary) in window

See when $CNC insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KPress release / Reg FDSep 168-K — Item 7.01: Press release / Reg FD
AI summary

Centene Corporation (CNC) participated in the Deutsche Bank Healthcare Summit, reaffirming its full-year 2026 guidance of GAAP EPS above $3.11 and adjusted EPS above $4.80. The conference presentation was made publicly available under Regulation FD. No changes to guidance, strategy, or financial targets were disclosed. This is a routine investor relations event confirming management's confidence in meeting 2026 financial targets amid ongoing Medicaid market dynamics.

8-KOfficer or director changeAug 178-K — Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
AI summary

Centene Corporation's CFO Andrew Asher announced his retirement effective December 31, 2026; he will serve as Strategic Advisor through the end of 2027 to ensure an orderly transition. Centene named Christopher Neczypor as his successor, effective January 1, 2027 — Neczypor (age 45) was CFO of Lincoln National Corporation from February 2023 to August 2026, with his Centene employment agreement signed August 12, 2026. The transition is planned and well-structured, with a year-long overlap period, reducing execution risk; Neczypor brings insurance and investment finance depth relevant to Centene's managed care and risk-bearing business.

3New insider — initial holdingsJul 283
AI summary

Paul J. Diaz filed Form 3 as a new reporting person at Centene Corporation (CNC), listing his address as 7700 Forsyth Blvd, St. Louis, MO — Centene's corporate headquarters, indicating a new director or officer appointment. The event date is July 28, 2026. No securities are listed as currently held in the form excerpt; this is a routine initial insider ownership disclosure.

8-KOfficer or director changeJul 288-K — Item 2.02: Earnings release · Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
AI summary

Centene Corporation (CNC) reported Q2 2026 financial results on July 28, 2026 via press release and investor presentation furnished as exhibits, and also disclosed one or more officer/director changes under Item 5.02. No headline financial figures or specific officer change details appear in the filing body excerpt. This is a combined earnings and governance disclosure for the managed care company; revenue, MCR, and guidance are in the attached press release.

3New insider — initial holdingsJun 223
AI summary

Lauren M. Tyler (director, St. Louis) filed a Form 3 initial beneficial ownership statement for Centene as of June 19, 2026. Administrative disclosure for newly elected director.

8-KOfficer or director changeJun 228-K — Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
AI summary

Centene's Board elected Lauren Tyler (JPMorgan Chase veteran, former Global Head of HR for Asset and Wealth Management) effective June 19, 2026, expanding from 9 to 10 members; she joins the Audit and Compensation committees from July 1. Governance addition with financial services and human capital expertise.

3New insider — initial holdingsMay 183
AI summary

Daniel P. Finke (7700 Forsyth Boulevard, St. Louis MO) filed a Form 3 initial beneficial ownership statement for Centene as of May 12, 2026. Administrative disclosure.

3New insider — initial holdingsMay 183
AI summary

Michael A. Carson (7700 Forsyth Boulevard, St. Louis MO) filed a Form 3 initial beneficial ownership statement for Centene as of May 12, 2026. Administrative disclosure for a second Centene reporter.

+ 6 other (2 10-Qs · 1 routine 8-K · 1 8-K · 1 13G) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Best Growth Stocks to Buy for October 1stzacks.com·2d ago5 Low P/B Stocks With Attractive Value and Strong Growth Potentialzacks.com·3d agoBest Growth Stocks to Buy for September 29thzacks.com·4d agoHere's Why Centene (CNC) is a Strong Value Stockzacks.com·8d agoBest Growth Stocks to Buy for September 24thzacks.com·9d ago

More in Medical - Healthcare Plans

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$OSCR$UNH$CI$CVS$CLOV$ALHC$HUM$MOH
Voices on X · last 7 days

No standout posts about $CNC on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport